4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-14-004818
CIK 0000806888operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 7:24 PM ET
Size
14.9 KB
Accession
0001437749-14-004818
Insider Transaction Report
Form 4
Wang David
Director
Transactions
- Award
Restricted Share Units
2014-03-19+2,622→ 2,622 total→ Common Stock (2,622 underlying) - Award
Stock Option (Right to Buy)
2014-03-19+5,000→ 5,000 totalExercise: $1.43Exp: 2024-03-19→ Common Stock (5,000 underlying)
Footnotes (4)
- [F1]Each restricted share unit represents a contingent right to receive one share of the company's common stock.
- [F2]100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date.
- [F3]Exercise prices shown are denominated in Canadian dollars.
- [F4]100% of the options vest on the one year anniversary of the date of grant.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 7:24 PM ET
- Size
- 14.9 KB